Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

fda_building_web

19 deaths from liver drug causes Intercept shares to tumble

September 22, 2017 Medical Communications, Sales and Marketing Intercept Pharmaceuticals, Ocliva, biotech, drugs, pharma, pharmaceutical

Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …
News

NICE recommends Bayer’s Eylea for myopic chorodial neovascularisation

September 22, 2017 Medical Communications, Sales and Marketing Bayer, Eylea, NICE, pharma, pharmaceutical

Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …
News

New therapy offers triple threat to HIV virus

September 22, 2017 Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
News
andrew_witty_gsk

Witty, Ex-CEO of GSK, keeps busy with two new roles in two days

September 21, 2017 Medical Communications : Pharma, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical

It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …
News
gp_commissioning_patient

Report finds variation in quality of care in GP practices across England

September 21, 2017 Medical Communications : Pharma, England, GP, NHS, biotech, drugs, pharma, pharmaceutical

Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …
News
scholar_rock_heather_faulds_headshot_bizwire

Scholar Rock prise Regulatory Affairs director away from Biogen

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Scholar Rock, biotech, drugs, pharma, pharmaceutical

Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins …
Appointment
computer_and_doctor

Standing together: Supercharging the clinical trial in Europe

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, clinical trials, drugs, pharma, pharmaceutical

The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cosentyx, Eli Lilly, Martin Skreli, Teva, pharma, top ten

This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …
News

Pfizer receives prostate cancer drug boost with trial results

September 15, 2017 Medical Communications, Research and Development Astellas, Pfizer, Xtandi, biotech, drugs, pharma, pharmaceutical

Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing …
News

FDA approves first-ever biosimilar for cancer treatment

September 15, 2017 Medical Communications, Sales and Marketing Amgen, Cancer, FDA, Mvasi, avastin, biosimilar

The FDA has announced the news that it has awarded approval to the first-ever biosimilar for the treatment of cancer …
News
gsk_hq_logo

GSK receives positive opinion for triple-therapy inhaler

September 15, 2017 Medical Communications, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical

GSK, alongside its partner Innoviva, has announced that it has received a positive opinion from the EMA’s CHMP for its …
News
sandoz

Sandoz psoriasis biosimilar tops reference product Humira in latest Phase 3 data

September 15, 2017 Medical Communications, Research and Development AbbVie, Humira, Novartis, Sandoz, adalimumab, biosimilar, biosimilars, pharma, pharmaceutical

Sandoz, the biologics and generics division of Novartis, has unveiled new Phase 3 data confirming the efficacy and safety profile …
News

Recipharm and Kancera collaborate to manufacture clinical trial supply

September 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed …
News
Press release
data

GDPR and Human Data Samples: Being ‘somewhat prepared’ is not enough

September 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, biotech, data, drugs, pharma, pharmaceutical

Thomas Hirse, Partner, and Paetrick Sakowski, Associate, CMS, discuss what pharmaceutical companies need to be aware of ahead of the …
Feature
martin_shkreli_2016

‘Pharma bro’ Shkreli heads to jail

September 14, 2017 Medical Communications Martin Shkreli, Shkreli, biotech, drugs, pharma, pharmaceutical

Martin Shkreli’s habit of being unable to stay out of the headlines continues, although this time with the repercussion that …
News
The Gateway to Local Adoption Series

Latest content

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026

Codis announces three senior business development appointments

June 18, 2026

US laboratory approval supports launch of lung cancer blood test

June 17, 2026

Study to examine ways of improving diabetes care for younger adults

June 16, 2026

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026